Special Focus on COVID-19 Immunity Testing

JAVASCRIPT DISABLED - This site works best with JavaScript enabled.

« Previous article
Track, Trace, and Tr...

Next article »
The Marketing Soluti...

27th September 2021 Content supplied by: rapidmicrobiology.com

Special rapidmicrobiology Focus on COVID-19 Immunity Testing

Booster shots given in developed countries, and only 1% vaccinated in less fortunate ones. Sooner or later, COVID-19 immunity testing needs to be done for a patient’s peace of mind or part of a global initiative. Read this special focus on COVID-19 immunity testing and contact a supplier now!

Comprehensive Analysis of Immune Responses to SARS-CoV-2

EUROIMMUN offers a powerful trio of tests for analysis of SARS-CoV-2 immune responses, encompassing quantitative measurement of anti-S1/RBD antibodies, detection of neutralising antibodies targeting S1/RBD, and analysis of SARS-CoV-2-reactive T cells.
Find Out More

Rapid Antibody Test Manufacturer Wins Gold and Bronze at Recent Healthcare Award Ceremony

Developed by ProGnosis Biotech the Rapid Test 2019-nCoV Total Ig demonstrated 98,75% sensitivity and 100% specificity for total antibodies against SARS-CoV-2 in the latest clinical performance study.
Find Out More

Rapid IgM/IgG Antibody Test Vital for COVID-19 Vaccination Program

The Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit from Bioperfectus is an in vitro lateral flow diagnostic test used for the detection of novel coronavirus (SARS-CoV-2) IgM and IgG antibodies. It is easy-to-use and provides results in 10-15 minutes.
Find Out More

200+ Recombinant SARS-CoV-2 Variants Bank for Vaccine Research

Sino Biological has developed 200+ recombinant SARS-CoV-2 variants, covering Lambda, Delta, and more Variants of Concern (VOCs) and Variants of Interest (VOIs), which can be used to evaluate the efficacy of the antibodies and vaccination.
Find Out More

Evaluate Vaccination with Recombinant SARS-CoV-2 Antigens with Critical Mutations

Creative Diagnostics' collection of SARS-CoV-2 recombinant antigens covers mutations in Spike proteins and Nucleocapsid proteins. The reagents can be used to evaluate the efficacy of antibodies and vaccination.
Find Out More

Highly-Specific Neutralizing Antibodies for COVID-19 Vaccine Potency and Immunity Studies

Fapon Biotech's COVID-19 neutralizing antibodies (NAbs) can be used in array of assays used to determine vaccine potency and antibody detection. These reagents have demonstrated high affinity, sensitivity and specificity in several verification studies.
Find Out More

More news:
Evaluating Immune Response to COVID-19 using CE-IVD Neutralizing Antibody ELISA Kit

Bacterial and Viral Biomarker Test Gains US FDA Clearance

SARS-CoV-2 Neutralizing Antibody Test is FDA-EUA and CE-Marked

Score-Card Indicates Strength of COVID-19 Antibody Response and Possible Immunity

Please note : Any products described on this page are for Research Use Only and not intended for clinical diagnostic procedures unless otherwise stated.